ARTV
ArtivaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ARTV Profile
Artiva Biotherapeutics, Inc.
A clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies
Biological Technology
02/14/2019
07/19/2024
NASDAQ Stock Exchange
89
12-31
Common stock
5505 Morehouse Drive, Suite 100, San Diego, CA 92121
--
Artiva Biotherapeutics, Inc., was incorporated in Delaware on February 14, 2019. The company is a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients with devastating autoimmune diseases and cancer.
